di-methyl-Histone H3 (Lys4) Monoclonal Antibody ChIP Grade


  • Specification
  • Target Information
  • Related Products
Cat.No.:  EAb-0530
Product Name:  di-methyl-Histone H3 (Lys4) Monoclonal Antibody ChIP Grade
Description:  The mouse-derived antibody is purified with protein G-conjugated agarose followed by di-methylated histone H3 (Lys4) peptide affinity chromatography. It specifically recognizes histone H3 with lysine di-methylation at Lys4.
Antibody Type:  Monoclonal
Immunogen:  Synthetic di-methyl peptide corresponding to residues surrounding Lys4 of human histone H3
Host:  Mouse
Isotype:  IgG
Specificity:  H3 with lysine di-methylation at Lys4
Purification:  Antibodies are purified by protein G-conjugated agarose followed by di-methylated histone H3 (Lys4) peptide affinity chromatography.
Appearance:  Liquid
Applications:  ChIP, IP
Recommended Dilutions/Conditions:  IP: 1:25; ChIP: 1:25
Recommended dilutions/conditions may not be available for all applications. Specific conditions for reactivity should be optimized by the end user.
Species Reactivity:  Eukaryotes
Storage:  -20°C
Storage Buffer:  PBS with 50% glycerol and 0.01% sodium azide.
Warning:  For Research Use Only! Not For Use in Humans.
Scientific Background:  The ε-amino lysine acetylation of proteins is an important reversible modification controlling protein activity.The amino-terminal tails of core histones undergo lysine methylation inmultiple sites, termed as “histone code” or “epigenetic code”. Lysine methylation in core histones is a major determinant for the formation of activeand in active regions of the genome and therefore plays vital roles in multiple cellular events. In most species, lysine methylation occurs primarily on histones H3 (Lys4, 9, 27, 36, 79) and H4 (Lys20) and has been implicated in both transcriptional activation and silencing. Methylation in histones modulated by specific histone methylases (HMTs) and histone demethylases (HDMs) is impaired in the pathologies of cancer and other diseases and therefore,enzymes regulating histone lysine methylation have become promising targets for anti-cancer drugs.

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.